A study on trend of relapse in leprosy and factors influencing relapse

Indian Journal of Leprosy

Volumn 77, Issue 2, 2005, Pages 105-115

  Showkath Ali, M K ^a   Thorat, D M ^a   Subramanian, M ^a   Parthasarathy, G ^a   Selvaraj, U ^a   Prabhakar, V ^a  

^a Central Leprosy Teaching and Research Institute India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LEPROSTATIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; FEMALE; FOLLOW UP; GENDER; HEALTH SURVEY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MULTIBACILLARY LEPROSY; NEUROLOGIC DISEASE; PAUCIBACILLARY LEPROSY; POLYPHARMACY; RECURRENCE RISK; RELAPSE; RELEASED FROM TREATMENT; RETROSPECTIVE STUDY; RISK FACTOR; SKIN DEFECT; TREATMENT OUTCOME;

ADULT; CHILD; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDIA; LEPROSTATIC AGENTS; LEPROSY; LOGISTIC MODELS; MALE; MINOCYCLINE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM LEPRAE; OFLOXACIN; RECURRENCE; RETROSPECTIVE STUDIES; RIFAMPIN; RURAL POPULATION;

EID: 21644471637     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ekambaram V, Rao MK (1991). Relapse rate of paucibacillary leprosy patients after multidrug therapy in North Arcot District. Indian J Lepr 63: 33-42
2. Grugni A, Nadkarni NJ, Kini MS et al (1990). Relapses in paucibacillary leprosy after MDT - a clinical study. Int J Lepr Other Mycobact Dis 58:19-24
3. Naafs B (1995). Features of relapse in paucibacillary leprosy after multidrug therapy. Indian J Lepr 67: 61-7
4. NLEP (1993). Guidelines for multidrug treatment in endemic districts. New Delhi: Leprosy Division, Directorate General of Health Services, Ministry of Health and Family Welfare
5. Noordeen SK (1991). A look at world leprosy. Lepr Rev 62: 72-86
6. Pandian TD, Muliyil J, Vellut C (1991). Risk of relapse among non- lepromatous patients released from treatment after dapsone monotherapy. Lepr Rev 62: 288-96
7. Pattyn SR, Groenen G, Bourland J et al (1988). The incubation time of relapses after treatment of multibacillary leprosy with rifampicin-containing regimens. Eur J Epidemiol 4: 231-4
8. Ramu G, Desikan KV (1988). A follow up study of borderline tuberculoid leprosy. Indian J Lepr 60: 26-33
9. Ramu G (1995). Clinical features and diagnosis of relapses in leprosy. Indian J Lepr 67: 45-59
10. Gebre S, Saunderson P, Byars P (2000). Relapse after fixed duration of MDT: The AMFES cohort. Lepr Rev 71: 325-31
11. WHO (1982). Chemotherapy of leprosy for control programmes. WHO Tech Rep Ser No 675. Geneva: World Health Organization
12. WHO (1988). A guide to leprosy control. Second edition. Geneva: World Health Organization
13. WHO (1995). Risk of relapse in leprosy. (Symposium paper). Indian J Lepr 67: 13-26. Unpublished document WHO/CTD/Lep/94.1
14. WHO (1997): A guide to eliminating leprosy as a public health problem. Second edition. Geneva: World Health Organization
15. WHO (1998). Expert Committee on Leprosy. Seventh report. WHO Tech Rep Ser No 874. Geneva: World Health Organization